Deutsche Bank’s Biogen BIIB Stock Holding History

Deutsche Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12	Closed	-$3K	–	4251
2021 Q3	$3K	Hold	12	–	–	﹤0.01%	4347
2021 Q2	$4K	Hold	12	–	–	﹤0.01%	4520
2021 Q1	$3K	Buy	+12	New	+$3.24K	﹤0.01%	4497
2020 Q2	–	Sell	-47	Closed	-$15K	–	4260
2020 Q1	$15K	Sell	47 -77	-62%	-$23.4K	﹤0.01%	3977
2019 Q4	$36K	Hold	124	–	–	﹤0.01%	4091
2019 Q3	$28K	Sell	124 -1,382	-92%	-$322K	﹤0.01%	4199
2019 Q2	$351K	Buy	1,506 +482	+47%	+$111K	﹤0.01%	3503
2019 Q1	$241K	Sell	1,024 -228	-18%	-$71.8K	﹤0.01%	3895
2018 Q4	$376K	Buy	1,252 +400	+47%	+$128K	﹤0.01%	3516
2018 Q3	$301K	Hold	852	–	–	﹤0.01%	4047
2018 Q2	$248K	Hold	852	–	–	﹤0.01%	4194
2018 Q1	$233K	Buy	852 +777	+1,036%	+$241K	﹤0.01%	4111
2017 Q4	$23K	Hold	75	–	–	﹤0.01%	4634
2017 Q3	$23K	Sell	75 -14	-16%	-$4.15K	﹤0.01%	4536
2017 Q2	$24K	Buy	89 +14	+19%	+$3.7K	﹤0.01%	4532
2017 Q1	$20K	Sell	75 -25	-25%	-$7.07K	﹤0.01%	4500
2016 Q4	$28K	Buy	+100	New	+$29.6K	﹤0.01%	4511
2013 Q4	–	Sell	-196	Closed	-$1K	–	5403
2013 Q3	$1K	Buy	+196	New	+$43.9K	﹤0.01%	5378

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank's BIIB Position: Q1 2026 in Review

Deutsche Bank increased its Biogen (BIIB) stake by 12% in Q1 2026, buying an estimated $20.3M and bringing the position to 1,063,828 shares worth $195M. The position accounts for 0.06% of the portfolio, ranked #283.

Deutsche Bank first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $963M in Q1 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Deutsche Bank held 1,063,828 shares of Biogen worth $195M as of Q1 2026.
Deutsche Bank bought 110,100 Biogen shares in Q1 2026, an estimated $20.3M.
Biogen made up 0.06% of Deutsche Bank's portfolio in Q1 2026, its #283 holding.
Deutsche Bank first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
Deutsche Bank's Biogen position peaked at $963M in Q1 2018.
1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.